Economy · Full coverage
Israeli Regulator Fines Medical Company and Executives for Misleading Reports
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Center 1Unrated 1
First reported by Walla · 2 hours ago
What happened
Israel's Securities Authority fined Epitomie Medical NIS 1.3 million and its executives for misleading reports regarding a failed distribution deal with Nestle. The company plans to appeal the decision and market its weight-loss pill independently.
- 01Epitomie Medical fined NIS 1.3 million for misleading reports.
- 02Company executives also received significant personal fines.
- 03The fines stem from a failed Nestle distribution deal.
- 04Epitomie disputes the findings and will appeal.
- 05The company plans independent U.S. and Israeli market launch.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Israeli Weight-Loss Pill Developer Appoints New CEO to Revive Struggling CompanyAug 12, 2026Israeli Insurance Agency Fined 10.5 Million Shekels for Illegally Encouraging Early Pension WithdrawalsAug 17, 2026Israeli Privacy Authority Imposes Record Fine on Meuhedet Health Fund Under New Data Protection LawJul 27, 2026Former Value Base Executive Fined $33,000 for Insider Trading in Ari Nadlan DealJun 30, 2026Israeli Real Estate Developer Best Faces Larger Financial Irregularities, Must Restate Reports5 days agoIsraeli Capital Market Authority Clarifies Fine on Naaman Insurance Agency Not Imposed on Owner6 days ago
